Matches in Nanopublications for { ?s ?p "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 23 of
23
with 100 items per page.
- assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP155938.RAELEwZowkXPsHhrIxiujGXVAXYT5H_PsSpNMpacoqt_0130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP155938.RAELEwZowkXPsHhrIxiujGXVAXYT5H_PsSpNMpacoqt_0130_provenance.
- NP236600.RAL_P3wWQ9uOIkwIDqBCW8L-n_uSnHk8yui7TCs-DhkcQ130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236600.RAL_P3wWQ9uOIkwIDqBCW8L-n_uSnHk8yui7TCs-DhkcQ130_provenance.
- NP888680.RA0QNSyJu_LyieQPO5QPXFmsjI45GMVUNu3fD2AVjSh-Q130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888680.RA0QNSyJu_LyieQPO5QPXFmsjI45GMVUNu3fD2AVjSh-Q130_provenance.
- NP436686.RA0lA8tT0wpTFJd3ydpBqz1CkcUsvMQ4BmM_NVPixdDKI130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436686.RA0lA8tT0wpTFJd3ydpBqz1CkcUsvMQ4BmM_NVPixdDKI130_provenance.
- NP696906.RA_HMe90jHfmwm3U1zULLVslu-roLKw_m5boRNJqTozMM130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP696906.RA_HMe90jHfmwm3U1zULLVslu-roLKw_m5boRNJqTozMM130_provenance.
- NP905774.RAN5-wh4x54cIf63W-Sx_QAhhqbVRsasSpO0xCF5poM5M130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905774.RAN5-wh4x54cIf63W-Sx_QAhhqbVRsasSpO0xCF5poM5M130_provenance.
- NP622684.RAdzwz7sQVHS3tYaACm0JRbgtFS8wCGSg-SWczI5bb1lc130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622684.RAdzwz7sQVHS3tYaACm0JRbgtFS8wCGSg-SWczI5bb1lc130_provenance.
- NP625140.RAcVFqFbxWmPG9SfYCbJew61pzKAHiRj7LEaG1rH44Piw130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625140.RAcVFqFbxWmPG9SfYCbJew61pzKAHiRj7LEaG1rH44Piw130_provenance.
- NP621316.RA9cFLf3oHo9m8xKLX0UwZgv-Khhx-Mw0jZRav3lp-zrc130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621316.RA9cFLf3oHo9m8xKLX0UwZgv-Khhx-Mw0jZRav3lp-zrc130_provenance.
- assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP694344.RAzn_89Gp7Hwyc8dzanugN1M2MLKIbT7BEbOACpfec0s8130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694344.RAzn_89Gp7Hwyc8dzanugN1M2MLKIbT7BEbOACpfec0s8130_provenance.
- NP694349.RA7R1dF75GCZKs6xZDif8HHlI_wR2LpdxJ4SHUxDfZJN4130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694349.RA7R1dF75GCZKs6xZDif8HHlI_wR2LpdxJ4SHUxDfZJN4130_provenance.
- NP694352.RARwETyoNDBIPuTqSnHSZ1xDCnWnILaY7ibTO14cuu1Ek130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694352.RARwETyoNDBIPuTqSnHSZ1xDCnWnILaY7ibTO14cuu1Ek130_provenance.
- assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP694347.RAEJ69ajCw28pJy74EH5Gk3kHCeWtSXFFpwp15NBAf474130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694347.RAEJ69ajCw28pJy74EH5Gk3kHCeWtSXFFpwp15NBAf474130_provenance.
- NP694351.RAOxinJSYXfOBShr7J4bkD2h8Ptx5q-2dqr5CnUMHH4D0130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694351.RAOxinJSYXfOBShr7J4bkD2h8Ptx5q-2dqr5CnUMHH4D0130_provenance.
- NP694353.RAFuhZ8gx25koaEyi0nJtmnGn2eQiBYtVeHfyImAy2NuY130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP694353.RAFuhZ8gx25koaEyi0nJtmnGn2eQiBYtVeHfyImAy2NuY130_provenance.
- NP623999.RAg6DbrfaxIIcCrzmKgM1cbeoFxsfpLmzmHosO5o6db_Y130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623999.RAg6DbrfaxIIcCrzmKgM1cbeoFxsfpLmzmHosO5o6db_Y130_provenance.
- NP232283.RAqUL59_ZhqX8r61XMWwnGJT7Ovnede9B7WZe1nm0KtbY130_assertion description "[PI3K/AKT and MAPK pathways are known to result in the phosphorylation and functional inactivation of tuberin (TSC2) of tuberous sclerosis complex thereby negating its inhibitory effects on mTOR, which in turn stimulates the translational machinery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232283.RAqUL59_ZhqX8r61XMWwnGJT7Ovnede9B7WZe1nm0KtbY130_provenance.